Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| fuscoatroside | C471532 | |
| fuscoatramide | C471533 | |
| glutinosin | C471534 | |
| halityloside D | C471535 | |
| Fbxw2 protein, mouse | C471536 | |
| PNU97018 | C471537 | |
| 4-O-isopropyl barbitone | C050060 | |
| prolactin-daunomycin ligand | C050061 | |
| SV48 | C050062 | |
| potassium aluminum tetrafluoride | C050063 | |
| RS 93427-007 | C050064 | |
| Lowicryl HM23 | C050065 | |
| Lowicryl K11M | C050066 | |
| hydromer | C050067 | |
| 7-methyl-8-oxoguanosine | C050068 | |
| 2-bromo-2'-deoxyadenosine | C050069 | |
| Misoprostol | D016595 | [A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.] |
| Vinculin | D016596 | [A cytoskeletal protein associated with cell-cell and cell-matrix interactions. The amino acid sequence of human vinculin has been determined. The protein consists of 1066 amino acid residues and its gene has been assigned to chromosome 10.] |
| ALL-80 protocol | C471580 | |
| Trimetrexate | D016597 | [A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.] |